BP Assay
Ongoing Challanges
- Pertussis (also known as whooping cough), a highly contagious respiratory illness unique to humans, is caused by the “Bordetella pertussis” bacteria.
- The disease is infectious from the onset of initial symptoms and remains so for at least two weeks after coughing starts. It is characterized by severe, uncontrollable coughing fits that can deplete the lungs of air and may persist for more than 10 weeks.
- Whooping cough poses significant health risks, especially to young children and immunocompromised individuals.
Product Overview
This assay is an automated, in vitro nucleic acid amplification test for the qualitative detection of “Bordetella pertussis” (BP) DNA in nasopharyngeal swab samples from individuals suspected of having a respiratory infection.
- A fast result in 29 mins
- Design to provide an accurate LOD: 500 copies/ml
- All-in-one cartridge avoid potential contamination
- One-step operation, no need redundant tranining
Clinical Value
- Distinguishing whooping cough and similar infections, aiding precise clinical interventions.
- Immediate diagnosis and early treatment of whooping cough can effectively control its spread and reduce the risk of severe cases and deaths following infection.
Reduces turn-around time, prevents unnecessary follow-up visits, and improves the patient experience.
Product Resources
EasyNAT® BP Assay
Brochure
EasyNAT® BP Assay
Instructions for Use
EasyNAT® BP Assay
SOP
